Medtronic ROA 2010-2024 | MDT
Medtronic ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2024-01-31 | $4.20B | $90.84B | 4.63% |
2023-10-31 | $4.10B | $90.09B | 4.48% |
2023-07-31 | $3.62B | $90.78B | 3.92% |
2023-04-30 | $3.76B | $90.95B | 4.08% |
2023-01-31 | $4.06B | $94.13B | 4.41% |
2022-10-31 | $4.32B | $93.24B | 4.72% |
2022-07-31 | $5.21B | $89.91B | 5.71% |
2022-04-30 | $5.04B | $90.98B | 5.50% |
2022-01-31 | $4.91B | $91.80B | 5.33% |
2021-10-31 | $4.70B | $91.76B | 5.03% |
2021-07-31 | $3.88B | $91.80B | 4.11% |
2021-04-30 | $3.61B | $93.08B | 3.79% |
2021-01-31 | $2.89B | $97.27B | 3.06% |
2020-10-31 | $3.54B | $95.89B | 3.79% |
2020-07-31 | $4.41B | $93.91B | 4.79% |
2020-04-30 | $4.79B | $90.69B | 5.24% |
2020-01-31 | $5.32B | $92.82B | 5.83% |
2019-10-31 | $4.67B | $91.05B | 5.18% |
2019-07-31 | $4.42B | $91.27B | 4.94% |
2019-04-30 | $4.63B | $89.69B | 5.20% |
2019-01-31 | $4.92B | $88.73B | 5.50% |
2018-10-31 | $2.26B | $88.15B | 2.48% |
2018-07-31 | $3.16B | $89.72B | 3.41% |
2018-04-30 | $3.10B | $91.39B | 3.25% |
2018-01-31 | $2.81B | $95.80B | 2.88% |
2017-10-31 | $5.02B | $94.46B | 5.12% |
2017-07-31 | $4.12B | $100.25B | 4.16% |
2017-04-30 | $4.03B | $99.86B | 4.08% |
2017-01-31 | $3.97B | $97.58B | 4.03% |
2016-10-31 | $4.24B | $98.41B | 4.25% |
2016-07-31 | $3.65B | $98.60B | 3.59% |
2016-04-30 | $3.54B | $99.64B | 3.44% |
2016-01-31 | $2.43B | $102.71B | 2.32% |
2015-10-31 | $2.32B | $104.95B | 2.49% |
2015-07-31 | $2.62B | $104.63B | 3.44% |
2015-04-30 | $2.68B | $106.69B | 4.49% |
2015-01-31 | $3.12B | $55.23B | 7.37% |
2014-10-31 | $2.91B | $38.78B | 7.68% |
2014-07-31 | $2.98B | $37.55B | 8.00% |
2014-04-30 | $3.07B | $37.94B | 8.36% |
2014-01-31 | $3.59B | $37.23B | 9.99% |
2013-10-31 | $3.81B | $36.47B | 10.79% |
2013-07-31 | $3.56B | $34.97B | 10.25% |
2013-04-30 | $3.47B | $34.90B | 10.12% |
2013-01-31 | $3.49B | $34.95B | 10.34% |
2012-10-31 | $3.44B | $33.96B | 10.41% |
2012-07-31 | $3.66B | $33.25B | 11.28% |
2012-04-30 | $3.62B | $32.82B | 11.34% |
2012-01-31 | $3.40B | $31.91B | 10.85% |
2011-10-31 | $3.39B | $31.75B | 10.93% |
2011-07-31 | $3.09B | $31.09B | 10.15% |
2011-04-30 | $3.10B | $30.68B | 10.39% |
2011-01-31 | $3.28B | $30.60B | 11.23% |
2010-10-31 | $3.18B | $29.31B | 11.44% |
2010-07-31 | $3.48B | $28.66B | 13.12% |
2010-04-30 | $3.10B | $28.09B | 12.26% |
2010-01-31 | $2.25B | $25.17B | 9.30% |
2009-10-31 | $2.11B | $24.28B | 8.97% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $105.230B | $31.227B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $185.422B | 24.34 |
Stryker (SYK) | United States | $128.275B | 31.81 |
Boston Scientific (BSX) | United States | $107.479B | 34.23 |
EssilorLuxottica (ESLOY) | France | $98.467B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $42.075B | 0.00 |
Haleon (HLN) | United Kingdom | $38.356B | 30.00 |
ResMed (RMD) | United States | $26.979B | 25.30 |
Terumo (TRUMY) | Japan | $24.775B | 34.99 |
Zimmer Biomet Holdings (ZBH) | United States | $24.604B | 15.84 |
Baxter (BAX) | United States | $20.430B | 14.90 |
Koninklijke Philips (PHG) | Netherlands | $19.242B | 15.35 |
Insulet (PODD) | United States | $11.496B | 60.36 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.440B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.860B | 23.42 |
BellRing Brands (BRBR) | United States | $7.238B | 38.92 |
Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
Haemonetics (HAE) | United States | $4.452B | 22.77 |
Perrigo (PRGO) | Ireland | $4.238B | 12.12 |
GN Store Nord (GNNDY) | Denmark | $3.889B | 25.18 |
Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.47 |
Envista Holdings (NVST) | United States | $3.441B | 13.09 |
QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
Neogen (NEOG) | United States | $2.591B | 24.92 |
Green Thumb Industries (GTBIF) | United States | $2.482B | 78.67 |
ICU Medical (ICUI) | United States | $2.303B | 17.19 |
TG Therapeutics (TGTX) | United States | $2.150B | 695.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.906B | 0.00 |
Owens & Minor (OMI) | United States | $1.848B | 17.74 |
Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.617B | 0.00 |
InMode (INMD) | Israel | $1.429B | 7.40 |
LeMaitre Vascular (LMAT) | United States | $1.414B | 46.66 |
National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
AdaptHealth (AHCO) | United States | $1.273B | 9.58 |
Warby Parker (WRBY) | United States | $1.254B | 0.00 |
AtriCure (ATRC) | United States | $1.094B | 0.00 |
MacroGenics (MGNX) | United States | $0.899B | 0.00 |
Canopy Growth (CGC) | Canada | $0.872B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.764B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.686B | 14.82 |
Cresco Labs (CRLBF) | United States | $0.674B | 0.00 |
Evolus (EOLS) | United States | $0.664B | 0.00 |
Jin Medical (ZJYL) | China | $0.608B | 0.00 |
Quanterix (QTRX) | United States | $0.596B | 0.00 |
Valneva SE (VALN) | France | $0.526B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.504B | 10.91 |
PetIQ (PETQ) | United States | $0.480B | 17.93 |
TerrAscend (TSNDF) | Canada | $0.462B | 0.00 |
ZimVie (ZIMV) | United States | $0.421B | 25.80 |
Biote (BTMD) | United States | $0.416B | 3.96 |
OraSure Technologies (OSUR) | United States | $0.402B | 6.66 |
Surmodics (SRDX) | United States | $0.373B | 40.26 |
Aurora Cannabis (ACB) | Canada | $0.366B | 0.00 |
Zynex (ZYXI) | United States | $0.352B | 40.52 |
Viemed Healthcare (VMD) | United States | $0.310B | 30.81 |
Cerus (CERS) | United States | $0.308B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.266B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.238B | 14.73 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
Omeros (OMER) | United States | $0.177B | 0.00 |
Veru (VERU) | United States | $0.177B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
High Tide (HITI) | Canada | $0.161B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.141B | 70.99 |
FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
InterCure (INCR) | Israel | $0.120B | 20.31 |
Fonar (FONR) | United States | $0.107B | 9.16 |
MariMed (MRMD) | United States | $0.100B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Brainsway (BWAY) | Israel | $0.080B | 0.00 |
Chimerix (CMRX) | United States | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.59 |
Apyx Medical (APYX) | United States | $0.051B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.95 |
Bright Green (BGXX) | United States | $0.035B | 0.00 |
Modular Medical (MODD) | United States | $0.033B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Flora Growth (FLGC) | United States | $0.020B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 74.09 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |